J. Virol., Jan 1996, 1-9, Vol 70, No. 1
Copyright © 1996, American Society for Microbiology

Evidence that the murine AIDS defective virus does not encode a superantigen

L Doyon, C Simard, RP Sekaly and P Jolicoeur
Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montreal, Canada.

The T-cell receptor repertoire was analyzed in C57BL/6 mice upon infection with helper-free stocks of the pathogenic murine AIDS (MAIDS) defective virus in order to demonstrate if, as previously reported, this virus encodes a superantigen. A polyclonal T-cell stimulation involving T cells expressing multiple V beta subsets occurred within the first week of infection, while late in the disease we could note only a 50% deletion of V beta 5 CD8+ cells. Transfection of the MAIDS virus genomic DNA into fibroblasts and B cells expressing major histocompatibility complex class II molecules failed to show any stimulation of cells expressing the specific V beta (V beta 5) previously reported to respond to MAIDS virus-infected cells. In addition, mice lacking V beta 5 cells did not show any significant decrease in susceptibility to the disease compared with mice expressing V beta 5 and bred on the same genetic background. Our in vivo and in vitro results fail to demonstrate a role for a superantigen encoded by the MAIDS defective viral genome in the pathogenesis of MAIDS.

This article has been cited by other articles:

• Harris, D. P., Koch, S., Mullen, L. M., Swain, S. L. (2001). B Cell Immunodeficiency Fails to Develop in CD4-Deficient Mice Infected with BM5: Murine AIDS as a Multistep Disease. J. Immunol. 166: 6041-6049 [Abstract] [Full Text]  
• Tenser, R. B. (1998). Trigeminal neuralgia: Mechanisms of treatment. Neurology 51: 17-19 [Abstract] [Full Text]  
• Kerr, S. J., Armati, P. J., Pemberton, L. A., Smythe, G., Tattam, B., Brew, B. J. (1997). Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology 49: 1671-1681 [Abstract] [Full Text]